The diagnosis of pseudotumor cerebri, or idiopathic intracranial hypertension (IIH), is most confidently established in the typical patient with evidence of papilledema, imaging that does not suggest a structural lesion, and a CSF examination that shows both normal composition and elevated intracranial pressure (ICP). Prompted by an increasing number of reports over the past decade, Friedman et al. 1 propose a revised set of diagnostic criteria for IIH, taking into account the most recent observations from neuroimaging studies. Although the patient with IIH is often a young woman who is above ideal body weight or obese, it is well-recognized that the disorder may also occur in obese men and in children, who are less likely to be obese than their adult counterparts. Several advances in the field prompted the expert authors to provide new guidance. First, a large study of children has redefined normal CSF opening pressure for children. 2 In the obese or sedated child, an opening pressure of 280 mm H 2 O has been suggested as the requirement to claim confidently that the ICP is increased. Otherwise, the diagnostic criteria for children and adults continue to rely on a CSF lumbar opening pressure of 250 mm H 2 O or greater.
Second, the cranial MRI scan is now recognized as showing changes suggestive of increased ICP. These findings include an empty sella, flattening of the posterior globes, distention of the perioptic subarachnoid spaces, and narrowing of the transverse venous sinuses. The finding of venous narrowing has contributed to a great debate as to whether this could be the cause of IIH, and where venous stenting might be considered in the IIH treatment algorithm. It is also unclear whether the venous stenosis is produced by increased ICP, is a primary factor in the genesis of the ICP, or could just be part of a vicious cycle. Nonetheless, the presence of these MRI findings alone can only suggest the diagnosis of intracranial hypertension in the absence of an elevated CSF opening pressure.
Third, it has been more clearly recognized that some patients with increased ICP may not manifest papilledema. This variability is likely due to anatomical differences and other factors affecting the optic nerve. The authors state that the diagnosis of IIH can now be met even in the absence of papilledema if the patient has documented elevated CSF pressure, fits all the typical clinical criteria, and has bilateral or unilateral sixth nerve palsy. In patients without a sixth nerve palsy, the MRI criteria above may only provide supportive evidence for the diagnosis. Of course, it can be argued that a sixth nerve palsy may not be necessary as a diagnostic requirement in those patients with a typical headache syndrome and a documented elevated opening CSF pressure (with normal constituents). Not every patient with increased ICP has papilledema or a sixth nerve palsy, so like most criteria they may not apply to every patient encountered in practice. Patients may have elevated ICP before papilledema develops, while others will never develop papilledema despite such elevation. In contrast, the authors also emphasize that one can make the diagnosis of probable pseudotumor cerebri syndrome if the patient has bilateral papilledema and the opening CSF pressure is normal and all other criteria are fulfilled. We encourage readers to be mindful of those patients placed in this category who may have bilateral optic perineuritis (bilateral optic neuritis with preserved visual acuity).
With the new criteria comes a proposed change in the terminology of this entity from idiopathic ICP to IIH syndrome. Friedman et al. believed that some patients have an identifiable secondary etiology and that the change in nomenclature emphasizes the need for etiology-specific treatment. This important point is well-taken. However, we think that the name of this entity will continue to be debated far and wide as the term IIH does not in itself point to the hallmark of this condition: elevated ICP. As such, even addition of the word "syndrome" does not add clarity to the nomenclature. Care will still need to be taken to avoid confusion with orbital inflammatory pseudotumor and other neuro-ophthalmic conditions. Sometimes, it is just necessary to spell the condition out to provide the best communication for those patients who have secondary etiologies for their increased ICP.
